Interest of a Specific Care Pathway for the Management of Catamenial Epilepsy

NCT05898152 | Unknown

• 2 other identifiers: RC31/23/00552023-A00280-45
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This is a study of patients with catamenial epilepsy. Catamenial epilepsies are defined as epileptic seizures during the menstrual cycle. Today, there are no recommendations and no care pathway for these patients. The aim of this study is to assess the number of patients reporting a link between the occurrence of their epileptic seizures and their menstrual cycle.

Conditions

Epilepsy Menstrual

Keywords

Catamenial epilepsy; Menstrual cycle

Outcome Measures

Primary Outcomes (1)

• Number of reporting patients

  Number and proportion of patients reporting having a link between the onset of their epileptic seizures and their menstrual cycle based on the questionnaire they completed.

  4 months

Secondary Outcomes (6)

• Listening satisfaction

  4 months

• Satisfaction of taking charge

  4 months

• Rate of women with drug-resistant epilepsy

  4 months

• Reconciliation of catamenial epilepsy

  4 months

• Association between catamenial epilepsy and menstrual cycle

  4 months

Study Arms (1)

Adult patients with catamenial epilepsy

A questionnaire regarding the menstrual cycle and the catamenial epilepsy will be administrated to the participants.

Other: Data collection

Interventions

Data collection OTHER

A collection about patient's data demographic, neurologic and gynecologic follow-up and satisfaction will be review by questionnaire. And a calendar of epileptic seizures will be completed by patients on 4 months

Adult patients with catamenial epilepsy

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Women with catamenial epilepsy

You may qualify if:

• Adults patients (\>18 years)
• No menopausal
• Patients who have consulted in a Neurology department for refractory epilepsy
• Non opposition patient
• Affiliation to a social security scheme

You may not qualify if:

• Patients who understand French enough

Sponsors & Collaborators

• University Hospital, Toulouse: lead

Study Sites (1)

University Hospital Toulouse

Toulouse, 31059, France

Location

MeSH Terms

Interventions

Data Collection

Intervention Hierarchy (Ancestors)

Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Anna GOSSET, MD

  University Hospital, Toulouse

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 15, 2023
• First Posted: June 12, 2023
• Study Start: May 3, 2023
• Primary Completion: May 3, 2024
• Study Completion: November 3, 2024
• Last Updated: June 12, 2023

Record last verified: 2023-05

Locations

FR (1)